Le RQ - Search Results

1

Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia.

Pollyea DA, Barrett J, DiNardo CD, Michaelis LC, Roboz GJ, Le RQ, Norsworthy KJ, de Claro RA, Theoret MR, Pazdur R. Pollyea DA, et al. Among authors: le rq. Clin Cancer Res. 2022 Mar 1;28(5):816-820. doi: 10.1158/1078-0432.CCR-21-2124. Clin Cancer Res. 2022. PMID: 34753779

2

FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.

Przepiorka D, Le RQ, Ionan A, Li RJ, Wang YH, Gudi R, Mitra S, Vallejo J, Okusanya OO, Ma L, Yang Y, Patel P, Mezaache D, Shah R, Banerjee A, McLamore S, Maung AN, Goldberg KB, Pazdur R, Theoret MR, De Claro RA. Przepiorka D, et al. Among authors: le rq. Clin Cancer Res. 2022 Jun 13;28(12):2488-2492. doi: 10.1158/1078-0432.CCR-21-4176. Clin Cancer Res. 2022. PMID: 35135839 Free PMC article.

3

FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.

Le RQ, Wang X, Zhang H, Li H, Przepiorka D, Vallejo J, Leong R, Ma L, Goldberg KB, Pazdur R, Theoret MR, De Claro A. Le RQ, et al. Oncologist. 2022 Jun 8;27(6):493-500. doi: 10.1093/oncolo/oyac042. Oncologist. 2022. PMID: 35363318 Free PMC article. Clinical Trial.

4

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.

Le RQ, Li L, Yuan W, Shord SS, Nie L, Habtemariam BA, Przepiorka D, Farrell AT, Pazdur R. Le RQ, et al. Oncologist. 2018 Aug;23(8):943-947. doi: 10.1634/theoncologist.2018-0028. Epub 2018 Apr 5. Oncologist. 2018. PMID: 29622697 Free PMC article.

5

Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell-Depleted Human Leukocyte Antigen-Matched Sibling Transplantation.

Chokshi P, Anandi P, Jain N, Dunavin N, Le RQ, Ito S, Barrett J, Battiwalla M. Chokshi P, et al. Among authors: le rq. Biol Blood Marrow Transplant. 2015 May;21(5):954-5. doi: 10.1016/j.bbmt.2015.02.020. Epub 2015 Feb 21. Biol Blood Marrow Transplant. 2015. PMID: 25711513 Free article. No abstract available.

6

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy.

Rezvani K, Yong AS, Mielke S, Savani BN, Jafarpour B, Eniafe R, Le RQ, Musse L, Boss C, Childs R, John Barrett A. Rezvani K, et al. Among authors: le rq. Cancer Immunol Immunother. 2012 Jul;61(7):1125-36. doi: 10.1007/s00262-011-1187-z. Epub 2011 Dec 24. Cancer Immunol Immunother. 2012. PMID: 22198310 Free PMC article. Clinical Trial.

7

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Le RQ, Tian X, Jain NA, Lu K, Ito S, Draper DA, Anandi P, Hourigan CS, Dunavin N, John Barrett A, Battiwalla M. Le RQ, et al. Bone Marrow Transplant. 2015 Aug;50(8):1138-40. doi: 10.1038/bmt.2015.112. Epub 2015 May 18. Bone Marrow Transplant. 2015. PMID: 25985051 Free PMC article. No abstract available.

8

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

Pophali PA, Klotz JK, Ito S, Jain NA, Koklanaris E, Le RQ, Hourigan CS, Savani BN, Chawla K, Shanbhag S, Barrett AJ, Battiwalla M. Pophali PA, et al. Among authors: le rq. Exp Hematol. 2014 Feb;42(2):83-9. doi: 10.1016/j.exphem.2013.07.003. Epub 2013 Oct 17. Exp Hematol. 2014. PMID: 24141092 Free PMC article.

9

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT.

Jain NA, Ito S, Tian X, Kurlander R, Battiwalla M, Lu K, Savani BN, Malkovska V, Rezvani K, Le RQ, Shenoy A, Hourigan CS, Keyvanfar K, Koklanaris E, Superata J, Muranski P, Barrett AJ, Yong ASM. Jain NA, et al. Among authors: le rq. Bone Marrow Transplant. 2015 Feb;50(2):189-196. doi: 10.1038/bmt.2014.249. Epub 2014 Nov 10. Bone Marrow Transplant. 2015. PMID: 25387087 Free PMC article. Clinical Trial.

10

CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation.

Anand A, Anandi P, Jain NA, Lu K, Dunavin N, Hourigan CS, Le RQ, Chokshi PD, Ito S, Stroncek DF, Sabatino M, Barrett AJ, Battiwalla M. Anand A, et al. Among authors: le rq. Support Care Cancer. 2016 Feb;24(2):815-822. doi: 10.1007/s00520-015-2848-9. Epub 2015 Jul 21. Support Care Cancer. 2016. PMID: 26190358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page